Literature DB >> 12374849

Chemotherapeutic hope on the horizon for Plasmodium vivax malaria?

Robert G Ridley1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12374849      PMCID： PMC129674          DOI： 10.1073/pnas.232483699

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  16 in total

1.  Molecular characterization of dihydrofolate reductase in relation to antifolate resistance in Plasmodium vivax.

Authors:  Ubolsree Leartsakulpanich; Mallika Imwong; Sasithon Pukrittayakamee; Nicholas J White; Georges Snounou; Worachart Sirawaraporn; Yongyuth Yuthavong
Journal:  Mol Biochem Parasitol       Date:  2002-01       Impact factor: 1.759

Review 2.  Drug resistance in malaria parasites of animals and man.

Authors:  W Peters
Journal:  Adv Parasitol       Date:  1998       Impact factor: 3.870

3.  Kinetic properties of dihydrofolate reductase from wild-type and mutant Plasmodium vivax expressed in Escherichia coli.

Authors:  R Tahar; P E de Pécoulas; L K Basco; M Chiadmi; A Mazabraud
Journal:  Mol Biochem Parasitol       Date:  2001-04-06       Impact factor: 1.759

4.  Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria.

Authors:  N D Karunaweera; G E Grau; P Gamage; R Carter; K N Mendis
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

Review 5.  The neglected burden of Plasmodium vivax malaria.

Authors:  K Mendis; B J Sina; P Marchesini; R Carter
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

Review 6.  Malaria in 2002.

Authors:  Brian Greenwood; Theonest Mutabingwa
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

Review 7.  The pathogenic basis of malaria.

Authors:  Louis H Miller; Dror I Baruch; Kevin Marsh; Ogobara K Doumbo
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

8.  Pyrimethamine resistance in Plasmodium vivax malaria.

Authors:  M D YOUNG; R W BURGESS
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

9.  Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance.

Authors:  P E de Pécoulas; R Tahar; T Ouatas; A Mazabraud; L K Basco
Journal:  Mol Biochem Parasitol       Date:  1998-05-01       Impact factor: 1.759

10.  Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax.

Authors:  Michele D Hastings; Carol Hopkins Sibley
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-27       Impact factor: 11.205
View more
  5 in total

1.  Maturation of Plasmodium falciparum in multiply infected erythrocytes and the potential role in malaria pathogenesis.

Authors:  Augustine U Orjih
Journal:  Parasitol Res       Date:  2014-08-15       Impact factor: 2.289

2.  Crystal structure of dihydrofolate reductase from Plasmodium vivax: pyrimethamine displacement linked with mutation-induced resistance.

Authors:  Palangpon Kongsaeree; Puttapol Khongsuk; Ubolsree Leartsakulpanich; Penchit Chitnumsub; Bongkoch Tarnchompoo; Malcolm D Walkinshaw; Yongyuth Yuthavong
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-31       Impact factor: 11.205

3.  Improved assessment of plasmodium vivax response to antimalarial drugs by a colorimetric double-site plasmodium lactate dehydrogenase antigen capture enzyme-linked immunosorbent assay.

Authors:  Pierre Druilhe; Philippe Brasseur; Catherine Blanc; Michael Makler
Journal:  Antimicrob Agents Chemother       Date:  2007-03-26       Impact factor: 5.191

4.  Inhibition of Plasmodium falciparum field isolates-mediated endothelial cell apoptosis by Fasudil: therapeutic implications for severe malaria.

Authors:  Estelle S Zang-Edou; Ulrick Bisvigou; Zacharie Taoufiq; Faustin Lékoulou; Jean Bernard Lékana-Douki; Yves Traoré; Dominique Mazier; Fousseyni S Touré-Ndouo
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

5.  Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop.

Authors:  N Mühlberger; T Jelinek; J Gascon; M Probst; T Zoller; M Schunk; J Beran; I Gjørup; R H Behrens; J Clerinx; A Björkman; P McWhinney; A Matteelli; R Lopez-Velez; Z Bisoffi; U Hellgren; S Puente; M L Schmid; B Myrvang; M L Holthoff-Stich; H Laferl; C Hatz; H Kollaritsch; A Kapaun; J Knobloch; J Iversen; A Kotlowski; D J M Malvy; P Kern; G Fry; H Siikamaki; M H Schulze; G Soula; M Paul; J Gómez i Prat; V Lehmann; O Bouchaud; S da Cunha; J Atouguia; G Boecken
Journal:  Malar J       Date:  2004-03-08       Impact factor: 2.979
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.